Impact of surgery and chemotherapy on cellular immunity in pancreatic carcinoma patients in view of an integration of standard cancer treatment with immunotherapy. May 2009 - Int. J. Oncol.; 34(6):1019-6439 [PMID:19424589] [Bellone G] [Novarino A] [Vizio B] [Brondino G] [Addeo A] [Prati A] [Giacobino A] [Campra D] [Fronda GR] [Ciuffreda L]
A combination therapy of gemcitabine with immunotherapy for patients with inoperable locally advanced pancreatic cancer. Mar 2009 - Pancreas; 38(3):1536-4828 [PMID:19276867] [Hirooka Y] [Itoh A] [Kawashima H] [Hara K] [Nonogaki K] [Kasugai T] [Ohno E] [Ishikawa T] [Matsubara H] [Ishigami M] [Katano Y] [Ohmiya N] [Niwa Y] [Yamamoto K] [Kaneko T] [Nieda M] [Yokokawa K] [Goto H]
A phase I/II study of a MUC1 peptide pulsed autologous dendritic cell vaccine as adjuvant therapy in patients with resected pancreatic and biliary tumors. Mar 2009 - Cancer Ther; 6(B):1543-9143 [PMID:19129927] [Lepisto AJ] [Moser AJ] [Zeh H] [Lee K] [Bartlett D] [McKolanis JR] [Geller BA] [Schmotzer A] [Potter DP] [Whiteside T] [Finn OJ] [Ramanathan RK]
Countering tumor-induced immunosuppression during immunotherapy for pancreatic cancer. Feb 2009 - Expert Opin Biol Ther; 9(3):1744-7682 [PMID:19216622] [Morse MA] [Hall JR] [Plate JM]
[Specific immune against pancreatic cancer induced by dendritic cells pulsed with mutant K-ras peptide] Dec 2008 - Zhonghua Yi Xue Za Zhi; 88(28):0376-2491 [PMID:19062734] [Yang B] [He Y] [Sun DL] [Zou Y] [Qin XH] [Huang BH]
Biological approaches to therapy of pancreatic cancer. Oct 2008 - Pancreatology; 8(4-5):1424-3911 [PMID:18724071] [Wong HH] [Lemoine NR]
Immunotherapy of pancreatic carcinoma. Jun 2008 - Curr Opin Investig Drugs; 9(6):1472-4472 [PMID:18516755] [Märten A] [Büchler MW]
Immunotherapy of pancreatic carcinoma. May 2008 - ; 3(2):1574-8871 [PMID:18474022] [Märten A]
Adoptive immunotherapy for pancreatic cancer using MUC1 peptide-pulsed dendritic cells and activated T lymphocytes. Apr 2008 - Anticancer Res.; 28(1B):0250-7005 [PMID:18383873] [Kondo H] [Hazama S] [Kawaoka T] [Yoshino S] [Yoshida S] [Tokuno K] [Takashima M] [Ueno T] [Hinoda Y] [Oka M]
Immunotherapeutic approaches in pancreatic cancer. Dec 2007 - Recent Results Cancer Res.; 177:0080-0015 [PMID:18084958] [Stieler J]
Dendritic cell-based vaccination combined with gemcitabine increases survival in a murine pancreatic carcinoma model. Aug 2007 - Gut; 56(9):0017-5749 [PMID:17395611] [Bauer C] [Bauernfeind F] [Sterzik A] [Orban M] [Schnurr M] [Lehr HA] [Endres S] [Eigler A] [Dauer M]
[Immunotherapeutic effects of beta-elemene combined with interleukin-23 gene-modified dendritic cells on murine pancreatic carcinoma] Sep 2006 - Ai Zheng; 25(9):1000-467X [PMID:16965646] [Tan G] [Wang ZY] [Wang XG] [Cheng L] [Yin S]
Dendritic cells pulsed with alpha-galactosylceramide induce anti-tumor immunity against pancreatic cancer in vivo. Jul 2006 - Int. Immunol.; 18(8):0953-8178 [PMID:16772371] [Nagaraj S] [Ziske C] [Strehl J] [Messmer D] [Sauerbruch T] [Schmidt-Wolf IG]
[Therapeutic effects of treatment of pancreatic carcinoma by interleukin-23 and apoptotic cell antigen-modified dendritic cell vaccine: experiment with mice] Jun 2006 - Zhonghua Yi Xue Za Zhi; 86(14):0376-2491 [PMID:16759530] [Tan G] [Wang ZY] [Yin S]
Efficacy of immuno-cell therapy in patients with advanced pancreatic cancer. Nov 2005 - Anticancer Res.; 25(6A):0250-7005 [PMID:16302730] [Kaneko T] [Goto S] [Kato A] [Akeyama A] [Tomonaga M] [Fujimoto K] [Miyamoto Y] [Eriguchi M] [Egawa K]
